But the latest findings are bad news for the world’s third biggest drug maker after it announced in September it planned to begin new clinical trials of the medicine as a treatment for type 2 diabetes, which is linked to obesity. …

article continues at yorik2002 brought to you by diabetes.medtrials.info and medtrials.info